SHR-1906 ( DrugBank: - )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
85	特発性間質性肺炎	2

85. 特発性間質性肺炎

---

臨床試験数 : 627 /  薬物数 : 443 - (DrugBank : 120) / 標的遺伝子数 : 99 - 標的パスウェイ数 : 212

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05722964 (ClinicalTrials.gov)	February 2023	11/1/2023	Study on Intravenous Injection of SHR-1906 in the Treatment of Idiopathic Pulmonary Fibrosis	Efficacy and Safety of Intravenous Infusion of SHR-1906 in Patients With Idiopathic Pulmonary Fibrosis: a Multicenter, Randomized, Double-blind, Parallel Placebo-controlled Phase II Trial	Idiopathic Pulmonary Fibrosis	Drug: SHR-1906;Drug: Placebo	Guangdong Hengrui Pharmaceutical Co., Ltd	NULL	Not yet recruiting	40 Years	80 Years	All	108	Phase 2	NULL
2	NCT04986540 (ClinicalTrials.gov)	August 10, 2021	27/7/2021	A Trial of SHR - 1906 in Healthy Subjects	A Phase 1, Randomized, Double-Blind, Placebo-Controlled Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Single IV Infusion of SHR-1906 in Healthy Subjects	Idiopathic Pulmonary Fibrosis	Drug: SHR-1906;Placebo	Guangdong Hengrui Pharmaceutical Co., Ltd	NULL	Completed	18 Years	55 Years	All	72	Phase 1	China